A Heparin-Mimic Macromolecule Promoted Endothelial Cell Adhesion

Area of Science:

• Biomaterials Science
• Vascular Biology
• Regenerative Medicine

Background:

• Vascular restenosis, a complication of stent implantation, involves smooth muscle cell migration and extracellular matrix deposition, leading to intimal hyperplasia.
• Current treatments using heparin are limited by risks like bleeding, supply issues, and storage requirements.
• Developing effective heparin alternatives is crucial for improving vascular interventional therapies.

Purpose of the Study:

• To evaluate sulfonated carboxymethyl chitosan (SCCS) as a heparin-mimicking coating for vascular stents.
• To assess the SCCS coating's ability to enhance endothelial cell adhesion and inhibit smooth muscle cell attachment.
• To determine the blood compatibility of the SCCS coating.

Main Methods:

• Immobilization of SCCS on a glass substrate using dopamine-mediated adhesion.
• In vitro assessment of endothelial and smooth muscle cell adhesion on SCCS-coated substrates.
• Evaluation of blood compatibility through whole blood cell analysis and complement activation assays.

Main Results:

• SCCS-coated substrates significantly promoted endothelial cell adhesion compared to carboxymethyl chitosan.
• SCCS coatings effectively inhibited smooth muscle cell attachment.
• Whole blood cell analysis and complement activation assays demonstrated excellent blood compatibility of the SCCS coating.

Conclusions:

• SCCS exhibits promising heparin-mimicking properties for preventing vascular restenosis.
• SCCS coatings show potential for application on vascular stents to improve outcomes of interventional therapy.
• This study presents a novel strategy for enhancing vascular interventional therapy through advanced biomaterials.